Handelsbanken Fonder Ab Pacific Biosciences Of California, Inc. Transaction History

Handelsbanken Fonder Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$5.97 - $10.36 $105,669 - $183,372	17,700 Added 49.03%	53,800 $528,000
Q2 2022 Aug 03, 2022	BUY	$4.02 - $10.43 $26,933 - $69,881	6,700 Added 22.79%	36,100 $160,000
Q1 2022 May 11, 2022	SELL	$8.43 - $20.9 $91,887 - $227,809	-10,900 Reduced 27.05%	29,400 $268,000
Q4 2021 Feb 08, 2022	BUY	$19.26 - $30.08 $25,038 - $39,104	1,300 Added 3.33%	40,300 $825,000
Q2 2021 Aug 03, 2021	BUY	$22.3 - $36.02 $218,540 - $352,996	9,800 Added 33.56%	39,000 $1.36 Million
Q1 2021 Apr 29, 2021	SELL	$26.38 - $51.15 $166,194 - $322,245	-6,300 Reduced 17.75%	29,200 $973,000
Q4 2020 Feb 11, 2021	BUY	$10.5 - $28.5 $372,750 - $1.01 Million	35,500 New	35,500 $921,000

258

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $380M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.